DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1CLARITHROMYCIN
02 1DARIFENACIN HYDROBROMIDE
03 1ETODOLAC
04 1METOPROLOL SUCCINATE
05 1MINOCYCLINE HYDROCHLORIDE
06 1MORPHINE SULFATE
07 1QUETIAPINE FUMARATE
08 2RANOLAZINE
01 165154
02 165485
03 175665
04 178761
05 1206252
06 1207206
07 1207664
08 1209953
09 1211291
01 9No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : CLARITHROMYCIN
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 65154
Country : US
Patented : No
Drug : QUETIAPINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 206252
Country : US
Patented : No
Drug : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 209953
Country : US
Patented : No
Drug : MINOCYCLINE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 65485
Country : US
Patented : No
Drug : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 211291
Country : US
Patented : No
Drug : DARIFENACIN HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 207664
Country : US
Patented : No
Drug : MORPHINE SULFATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 78761
Country : US
Patented : No
Drug : ETODOLAC
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 75665
Country : US
Patented : No
Drug : METOPROLOL SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 207206
Country : US
Patented : No
LOOKING FOR A SUPPLIER?
